Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718325 | 0.78 | ALDH1A1 (0.31) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL20626280 | 0.77 | KDM4E (0.33) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL20534467 | 0.74 | CYP1A2 (0.41) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL30620185 | 0.74 | CYP1A2 (0.41) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL28468438 | 0.74 | KDM4E (0.36) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL1470735 | 0.72 | ALDH1A1 (0.35) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL29690232 | 0.72 | ALDH1A1 (0.35) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL12405322 | 0.71 | KDM4E (0.39) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL3845195 | 0.70 | KDM4E (0.41) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL15274205 | 0.68 | L3MBTL1 (0.43) | KDM4EMEN1ALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080265750-A1 | Triphenylene Compounds, Method of Manufacturing the Same and Organic Electroluminescent Devices Employing the Same | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (JP) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080265750-A1 | Triphenylene Compounds, Method of Manufacturing the Same and Organic Electroluminescent Devices Employing the Same | SMARCC2, SMARCC1, TERT | KDM4E 975/4885MEN1 1293/4885ALDH1A1 755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.